Cellectis SA (STU:ZVAA)
€ 1.48 -0.03 (-1.99%) Market Cap: 148.13 Mil Enterprise Value: -4.47 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 49/100

Q2 2023 Cellectis SA Earnings Call Transcript

Aug 04, 2023 / 12:00PM GMT
Release Date Price: €1.62 (+0.62%)
Operator

Good morning, and everyone, welcome to Cellectis Second Quarter 2023 Earnings Call. (Operator Instructions)

Please be aware that today's conference call is being recorded. I'd now like to introduce the first speaker, Arthur Stril, Chief Business Officer. You may begin.

Arthur Stril
Cellectis S.A. - Chief Business Officer

Good morning, and welcome, everyone, to Cellectis Second Quarter 2023 Corporate Update and Financial Results Conference Call.

Joining me on the call today with prepared remarks are Dr. Andre Choulika, our Chief Executive Officer; Dr. Bing Wang, our Chief Financial Officer; and Dr. Mark Frattini, our Chief Medical Officer.

Yesterday evening, Cellectis issued a press release reporting a corporate and business update for the second quarter 2023 and its non-audited financial results for the 6-month period ended June 30, 2023. As disclosed in our press release published yesterday, the report, including our nonaudited financial statements for Q2 will be released in the coming days.

As a reminder, we will make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot